DDB1 overexpression
|
Multiple Myeloma
|
DDB1 overexpression
|
Multiple Myeloma
|
lenalidomide Sensitive: C3 – Early Trials
|
lenalidomide Sensitive: C3 – Early Trials
|
DDB1 overexpression
|
Multiple Myeloma
|
DDB1 overexpression
|
Multiple Myeloma
|
thalidomide Sensitive: C3 – Early Trials
|
thalidomide Sensitive: C3 – Early Trials
|